Introduction
T he range of daily dietary iodine intake by humans varies by more than two orders of magnitude. Thyroidal uptake of iodide and synthesis of iodinated organic species (i.e., organification of iodine) varies with intake, yet animals and humans secrete remarkably constant levels of triiodothyronine (T 3 ) and thyroxine (T 4 ) regardless of intake. A wide range of adaptive responses to iodide has been demonstrated. Thyroid autoregulation has been extensively studied, but it has not been possible to fashion a cohesive explanation describing the wide range of clinical and experimental observations. It is clear, however, that the organification (i.e., iodination) of iodine plays an important regulatory role in the thyroid exposed to chronic excess iodide.
The reaction products of thyroperoxidase (TPO) are a function of iodide concentration. This is not surprising as iodide reacts with a key intermediate of TPO (Enz-Fe IV -OI) to form I 2 (1) . Taurog suggested that formation of molecular iodine (I 2 ) under elevated iodide concentrations could be responsible for aspects of iodide regulation (2). Taurog's suggestion is intriguing since I 2 has distinctive properties that are not generally appreciated. I 2 is a hydrophobic species that is highly polarizable. I 2 readily partitions into hydrophobic environments and nonspecifically iodinates double bonds; the partition coefficient of I 2 in a chloroform=H 2 O mixture is about 100. I 2 is the only species in topical iodinedisinfectants that is able to penetrate into epidermis (3) . I 2 has the chemical capacity to nonspecifically iodinate amino acids, proteins, and lipids (4) .
The oxidation of iodide is a necessary step to incorporate iodine into bioactive molecules. The oxidation of iodide by reactive oxygen species (ROS) like hydrogen peroxide (H 2 O 2 ) has been studied since the early 1920s (5) . These reactions yield a complex mixture of different iodine species. One factor that contributes to this complexity is the range of oxidation states associated with iodine species: À1 to þ5, for example, À1 (iodide: I À ); þ1 (hypoiodic acid: HOI); þ5 (iodate: IO 3 À ) as shown in Equation 1.
Several of the oxidized iodine species formed from iodide oxidation have the potential to react with both water and I À . This complex pattern of reactions yields nonlinear reaction kinetics. A variety of approaches have been used to study the kinetic properties of the individual reactions underlying the aqueous reactions formed by iodide oxidation. Gottardi integrated these results into a computer model that calculates the equilibrium distribution of iodine species as a function of both pH and initial reactant (e.g., I
À , I 2 ) concentrations (6) . Several of the reactions that occur under physiological conditions are shown in Equations 2-8.
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The iodination of organic molecules requires iodide oxidation. TPO-catalyzed oxidation of iodide leads to I 2 formation at iodide concentrations found in the thyroid ($10 mmol). In addition to biological molecules, I 2 reacts with water and iodide in an aqueous environment. The equilibria described in these reactions would be affected by the interaction of some iodine species (e.g., I 2 ), with mammalian proteins and lipids as well as the addition of iodide from the action of deiodinases and dehalogenases. Nevertheless, the interactions identified in Equations 2-8 are operative in biological matrices such as the thyroid. I 2 formed within a biological environment is subject to well-defined thermodynamic constraints. The potential impact of the properties of aqueous iodine equilibria on iodine physiology has not been explored. The iodine species that exist at a pH 7. ). Under normal physiological conditions, there are two species that can serve as iodinating agents: HOI and I 2 . Both HOI and I 2 iodinate organic species, but they do not exhibit an identical selectivity in this regard. Dunford and Ralston demonstrated that HOI, not I 2 , is the species that iodinates tyrosine in aqueous environments that contain both I 2 and HOI (7) . The disparity in the capacity of HOI and I 2 to iodinate tyrosine may be due to their distinct physiochemical properties.
Experiments and computer models demonstrate that iodide has a major influence on the ratio of I 2 =HOI at pH 7.4 (6) . The equations that govern aqueous iodine equilibria exhibit a nonlinear response to iodide with respect to the ratio of I 2 =HOI; increased iodide decreases this ratio. A 10 À3 molar solution of I 2 dissolved in water yields a concentration of HOI that is 10 À3.9 molar. If 10 À3 or 10 À2 molar iodide is added to this solution, the concentration of HOI will decrease to 10 À4. 8 
and 10
À6.5 molar, respectively (8) . In comparison, the concentration of I 2 only decreases to 10 À3.2 and 10 À3.9 molar, respectively.
The consequence of introducing increased I À into a solution of oxidized I À species is to shift the iodinating capacity away from a water-soluble species (HOI) toward a hydrophobic species (I 2 ). The concentration and ratio of the unbound iodinating species (HOI=I 2 ) is therefore a function of I À concentration.
Iodination-A Model
In mammals, a combination of chemical and biochemical (extra-enzymatic) processes appears to be responsible for the synthesis of iodinated organic species (e.g., lipids, amino acids, proteins). In particular, the chemical equilibria and reactions of I 2 in an aqueous environment may play a role in determining which species are iodinated. The model proposed in this manuscript is outlined in Figure 1 .
The first step in the mammalian oxidation of iodide is a two-electron transfer from the TPO to hydrogen peroxide forming water and the intermediate Enz- IV -OI intermediate is thought to directly iodinate the tyrosyl groups on Tg although the precise mechanism is not settled. Tyrosine and MIT also react with Enz-Fe IV -OI to generate free radical intermediates that catalyze coupling of adjacent iodotyrosyl groups on Tg to form Tg-bound thyroxine.
The Enz-Fe IV -OI intermediate exhibits limited specificity and reacts with a variety of different substrates including aromatic phenols, amines, and iodide. The reaction of EnzFe IV -OI with iodide leads to the formation of I 2 . A second iodination pathway is triggered when I 2 is generated. Some of the I 2 formed is hydrolyzed to HOI; unbound HOI can iodinate tyrosyl groups and contribute to the formation of T 3 and T 4 . However, some of the I 2 reacts with lipids and proteins to yield iodinated organic species.
Iodinated lipids are believed to play an important role in thyroid autoregulation (9) . Four different iodinated lipids have been identified in mammalian thyroid cells: 6-iodo-5-hydroxy-8,11,14-eicosatrienoic acid (d-iodolactone), a-iodohexadecanal (a-IHDA), 5-iodo-7,10,13,16,19-docosapenta-enoic acid (g-lactone), and 14-iodo-l5-hydroxy-5,8,11-eicosatrienoic acid (olactone). Two of these four identified iodinated lipids are known to express biological activity. This suggests a nonspecific iodination process that is consistent with the proposed model. However, this model also predicts that I 2 should be This study was conducted to determine whether the thyroid lipids of hogs maintained on an iodine-sufficient diet were iodinated. The term ''iodine'' in this manuscript refers to all species of iodine, including organified iodine.
Materials and Methods
Hogs in this study were treated in accord with accepted standards of humane animal care. The diet of hogs was supplemented with iodine according to established standards (10) . Mineral premix was added to feed to yield an iodine concentration of 0.15 ppm throughout the life cycle of the animals. A survey of nine commercial plants conducted in 1992 observed an iodine concentration in feed that ranged from 0.15 to 2.20 ppm. The bottom of this range was selected because it is more comparable to the recommended intake in humans. The average weight of a slaughtered hog is about 110 kg. Hogs consume about 166 kg of feed over & 170 days of growth. Daily feed consumption depends upon body weight. Scaling feed intake linearly with age yields feed consumption of about 1.95 kg at slaughter. An iodine concentration of 0.15 ppm yields about 300 mg of iodine at slaughter for a 110-kg hog.
Hogs were slaughtered at 6 months AE 2 weeks. Hog thyroids from 15 slaughtered animals were frozen and then minced to 3=8 inch in a refrigerated room. The minced samples were spread uniformly on a stainless steel pan and placed on heat shelf vacuum dryer (718C) and dried. The dried samples were defatted with heptane, to residual less than 5% fat. Defatted product was run through magnetic separators, positioned in a Fitz Mill and milled to a coarse powder. The samples were ground to a fine powder with a ball mill (porcelain balls) and then blended in a V-mixer. The extracted lipids were stored in a sealed glass bottle at À 88C.
Lipid extraction and washing of the extract were conducted according to the method of Folch et al. (11) in the laboratory of Dr. Tilak Dhiman at Utah State University. Extracted fat was derivatized to methyl esters using an alkaline methylation procedure by mixing 40 mg of fat with a sodium methoxide methylation reagent (NaOCH 3 =MeOH) as previously described (12) . After fatty acid (FA) methyl esters (FAMEs) were formed, anhydrous calcium chloride pellets were added and allowed to stand for 1 hour to remove water in the sample. Samples were then centrifuged at 2600 g at 58C for 5 minutes.
Separation of FA was achieved by gas chromatography (model 6800 Series II; Hewlett Packard, Avandale, PA) fitted with a flame ionization detector. Samples containing methyl esters in hexane (1 mL) were injected through the split injection port (100:1) onto CP-Sil 88 fused silica 100 mÂ0.25 mm column, 0.20 mm film (Varian CP-Sil 88 model; Varian, Palo Alto, CA). Oven temperature was set at 808C and held for 10 minutes, then ramped to 1908C at 128C=min for 39 minutes. The temperature was then ramped to 2188C at 208C=min and held for 21 minutes. Injector and detector were set at 2508C. Total run time was 70.57 minutes.
Heptadecadenoic acid was used as qualitative internal standard. Each peak was identified using FA and FAMEs (Nu-Chek Prep, Elysian, MN; Matreya, Pleasant Gap, PA; and SupelcoÔ 37 Component FAME mix, Supelco, Bellefonte, PA). Percentage of each FA was calculated by dividing the area under the FA peak (minus the area under the peak for heptadecanoic acid) by the sum of the areas under the total reported FA peaks. FAs were reported as g=100 g of FAMEs.
The FA iodine content of FA was determined using inductively coupled plasma (ICP) analysis. Two grams of FA was heated in 20 mL of distilled water (dH 2 O) at 958C. After 30 minutes, 35 mL of a 3% ammonium solution was added and the ICP=MS (m=z 127) analysis was conducted immediately. Serum iodine was also measured with ICP after filtration through a 0.45 mm mixed cellulose ester syringe filter. Table 1 lists the FA composition of the thyroid tissue. C18 FAs constituted more than 75% (w=w) of the FA present with C18:1 12-t comprising more than 64% of the sample; C18:1 13, 14-t, 6,7,8-c constituted 8.85%, and C18:0 (stearic acid) was 3.72%. The only unsaturated FAs at a concentration above 1% were myristic acid (C14:0; 1.64%) and palmitic acid (C16:0; 18.08%). Overall saturated FAs comprised 25.28% and unsaturated FAs, 74.72%. The assay for iodine yielded a value of 170 mg of iodine per kilogram of hog thyroid lipid. The ''average'' molecular weight of the FAs in Table 1 is 277.1; the ratio noniodinated to iodinated lipids can be estimated to be 250-275 assuming mono-iodination. The concentration of serum iodine was 38.4 AE 7.1 mg=L.
Results
Samples were analyzed for an additional 28 FAs none of which were detected. This list includes butyric acid, caproic acid, caprylic acid, undecanoic acid, tridecanoic acid, myristoleic acid, oleic acid, vaccenic acid, linoleic acid, arachidic acid, g linolenic acid, cis-9,t-11-octadecadienoic acid (CLA 1), t-9-t-11-octadecadienoic acid (CLA 2), eicosadienoic acid, behenic acid, homogammalinolenic acid, arachidonic acid, lignoceric acid, cicosapentanoic acid (EPA), heptadecanoic acid, docosapentanenoic acid (DPA), and docosahexaenoic acid (DHA). 
Discussion
The thyroid is known to iodinate organic species other than tyrosyl groups in response to elevated dietary iodine intake. The underlying mechanism responsible for the iodination of nontyrosyl groups is an open question, but peroxidases are the only known enzymes with an established capacity to oxidize iodide. Several iodinated lipids have been identified in the mammalian thyroid challenged with elevated iodide levels. Two of these iodinated lipids express an antiproliferative activity and apparently play a role in thyroid autoregulation. Dugrillon (13) speculated about the potential role iodinated lipids play in goitrogenesis and tumorigenesis under normal physiological conditions; however, a mechanism responsible for iodination of organic species, such as lipids, under normal iodine intake has not been advanced.
We examined the FAs of hogs maintained on a diet that contained normal levels of iodine. The results indicate that hog thyroid does iodinate species other than tyrosyl groups during intake of iodine that is considered normal. Iodine comprised 0.017% (w=w) of the FAs of hog thyroid. When viewed from a clinical perspective, this result is surprising since we link dietary iodine intake with formation of T3 and T4. However, oxidized iodide species do not provide a high degree of synthetic specificity, and a range of iodinated organic species is to be expected.
The mechanism of TPO oxidation of iodide has been exhaustively examined, yet basic questions remain open; for example, is tyrosyl iodination of Tg effectuated by an enzyme-bound intermediate or by freely diffusing iodination equivalents? It is clear that TPO can catalyze the formation of I 2 by the interaction of iodide with the Enz-Fe IV -OI intermediate. Iodide competes for the Enz-Fe IV -OI intermediate with other potential substrates like tyrosyl groups. In this model, the formation of I 2 under normal physiological condition would be expected. The amount of I 2 formed is a function of iodide concentration.
The chemical properties of I 2 may limit the role that an enzyme could play in the synthesis of iodine organification. Peroxidases, the only mammalian enzyme known to oxidize iodide, can form a complex with hypoiodite HOI. No enzyme has been identified that forms a stable complex with I 2 . I 2 catalyzes a number of reactions of potential relevance to proteins; specifically, it (i) reacts with amino groups of lysine, histidine, and arginine, as well as the bases of nucleotides; (ii) oxidizes the sulphydral group of cysteine; (iii) iodinates tyrosine to form mono-and di-iodotyrosyl groups; and (iv) adds across double bonds.
The physical and chemical properties of I 2 may be inconsistent with an active-site-directed iodination mechanism based on I 2 .
Early life forms used iodide to neutralize ROS (14) . Berking et al. has shown that iodide and tyrosine are required to protect Aurelia aurita (jellyfish) from ROS (15) . ROS are neutralized when they oxidize iodide and yield I 2 and HOI. Tyrosine is needed to neutralize the reactive iodinating equivalents (HOI and I 2 ) formed from the oxidation of iodide. In the course of evolution, the mammalian thyroid has developed more complex strategies to neutralize iodination equivalents not directed to the synthesis of T 3 and T 4 . One of these mechanisms appears to be the iodination of lipids. Elevated iodide concentrations in the thyroid favor the formation of I 2 and the chemical logic of using iodinated lipids to modulate thyroid activity follows thereto.
The model proposed in Figure 1 is potentially applicable with all mammalian peroxidases-myeloperoxidase, lactoperoxidase, eosinophil peroxidase, and salivary peroxidaseprovided a high enough concentration of iodide can be reached in the relevant tissue. A possible role of extrathyroidal iodine has been discussed in the literature, suggesting that we do not have a complete understanding of iodine physiology. Excluding thyroidal hormones, our understanding of the role of iodinated organic species in mammalian physiology is extremely limited. Some researchers believe that our current level of iodine intake may predispose certain individuals to various disease states (16, 17) .
There is also indirect evidence that iodinated organic species other than thyroid hormones have biological activity. Several studies have analyzed the comparative effects of oral administration of I 2 versus iodide. Some studies that purport to examine orally administered I 2 suffer due to inappropriate handling of the I 2 species (18). However, five studies have either dissolved I 2 daily before use or generated I 2 at the time of administration by reaction with peroxide. Oral administration of I 2 results directly in the formation of iodinated species in the gastrointestinal tract (19) .
The comparative effects of I 2 and iodide in iodine-deficient Sprague-Dawley rats were first examined in 1995 (20) . Comparable amounts of orally administered I 2 and iodide caused different histopathological and endocrine patterns in thyroid and mammary glands of iodine-deficient rats. A subsequent study (21) examined the comparative effect of I 2 and iodide on induction and promotion of mammary tumors in Sprague-Dawley rats induced with N-nitroso-N-methyurea. Continuous I 2 administration reduced the incidence of mammary tumors by 70% as compared to 30% for controls and iodide. Tumor suppression was correlated with increased pendrin synthesis and lower levels of lipoperoxidation. Thrall observed that a substantial percentage of the iodine from orally administered I 2 combined with a lipid (22, 23) and concluded that I 2 has different pharmacological and toxicological properties than iodide.
The recommendation for the daily dietary intake of iodine has not considered potential health benefits from increased iodine intake; instead, it has understandably incorporated thyroid-related adverse events known to occur under elevated intake. Several categories of individuals experience an increased rate of thyroid-related adverse effects when exposed to elevated iodine. In fact, the suggested recommended dietary allowance (RDA) for iodine (0.125-1.1 mg=day) does not protect some susceptible patients as dietary variations within the RDA are correlated to thyroid-related adverse effects in susceptible individuals. However, controlled studies indicate that acute and sub-acute exposures of high levels of iodine in normal euthyroid individuals are without clinical effect. Entire population in Japan is known to excrete 5-30 mg daily throughout their life (24) .
The acute dose of iodide necessary to perturb thyroidstimulating hormone (TSH) from baseline in normal euthyroid individuals has been used to identify a safe upper
22
KESSLER AND HOOGE limit for dietary intake. A change in TSH values within the normal range is not an adverse effect, but it has been adopted as a proxy for increased risk of developing clinical hypothyroidism. Critics point to the fact that there is no controlled data supporting this assumption. While true, only epidemiological studies suggest that increased levels of dietary iodine are beneficial to the normal population; at this time, no controlled data support this supposition. The recommended upper limit suggested as safe for the public has been established mindful of a relatively small subset of the population that is sensitive to iodine. The methodology used to arrive at the recommended upper limit (1.1 mg=day) has not been validated by standards consistent with evidence-based medicine. The percentage of individuals in the United States that are iodine deficient or close to iodine deficient has doubled over the past several decades. It is entirely accurate to say that animals used for feedstock in the United States have their dietary iodine needs met more completely than the corresponding human population. Medicine is said to be a probabilistic activity; a rigorous process would hopefully incorporate a broader range of information than currently used to establish dietary guidelines for iodine.
There is substantial data indicating a relationship between mammary health and iodine intake. Iodine deficiency leads to cystic changes, periductal fibrosis, and lobular hyperplasia in estradiol-treated rats (25) . Iodine has a suppressive effect on carcinogen-induced tumors in rats, and suppressed tumors have a significantly higher uptake of iodine (26, 27) . Several clinical trials have demonstrated that supraphysiological levels of iodine can remediate symptoms associated with chronic clinical mastalgia; two of these trials were randomized and placebo controlled (28) (29) . There is no evidence that thyroid hormones have any role in these effects.
Diverse nonclinical and clinical observations indicate that iodinated organic species other than T3 and T4 can affect health. Inadequate concentrations of some of these organified species may predispose individuals to different disease states. Cann has postulated that low dietary intake is associated with breast cancer risk (30) and cardiovascular health (31) . The hypothesized iodinated species are likely to be present in low concentrations. In addition, organified molecules with no biological activity will almost certainly be present. The challenges inherent in elucidating these species and their clinical relevance are more daunting than those faced with T3 and T4. Nevertheless, an increased understanding of iodine physiology may lead to improved health outcomes in many individuals.
